S. 5029
118th Congress
Senate
Small Biotech Innovation Act
Official title: A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 12, 2024
Read twice and referred to the Committee on Finance.
Sep 12, 2024
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Finance.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
1
Cite this page
U.S. Congress. (2026). S. 5029: Small Biotech Innovation Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-5029/
"S. 5029: Small Biotech Innovation Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-5029/.
S. 5029, 118th Cong. (2026), https://openamerica.io/bill/118-S-5029/.
[S. 5029: Small Biotech Innovation Act](https://openamerica.io/bill/118-S-5029/)